Scarica l'app Stockscreener
40.84
8.22%
-3.66
Dopo l'orario di chiusura:
41.46
0.62
+1.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Rigel Pharmaceuticals Borsa (RIGL) Ultime notizie
Rigel Pharmaceuticals, Inc. announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Earnings Risk: Will Rigel Pharmaceuticals Inc. (RI2) stock gain from green policies - ulpravda.ru
Is Rigel Pharmaceuticals Inc. stock a buy in volatile markets2025 Major Catalysts & Long-Term Growth Stock Strategies - ulpravda.ru
Is Rigel Pharmaceuticals Inc. stock supported by strong cash flows2025 Support & Resistance & Real-Time Sentiment Analysis - ulpravda.ru
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance
Is Rigel Pharmaceuticals (NASDAQ:RIGL) Using Too Much Debt? - simplywall.st
Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio - The Manila Times
SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook, 2030Rigel Pharmaceuticals Lea - PharmiWeb.com
User - FinancialContent
Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference - StreetInsider
Best Momentum Stocks to Buy for January 6th - Yahoo Finance
Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance - Yahoo Finance
Technical Reactions to RIGL Trends in Macro Strategies - Stock Traders Daily
Is Rigel Pharmaceuticals Inc. stock near bottom after decline2025 Year in Review & Growth Focused Entry Reports - moha.gov.vn
What analysts say about Rigel Pharmaceuticals Inc RI2 stockLow Beta Stocks & Low Risk Investment Growth - earlytimes.in
Jhandewalas Foods Limited Earnings Review What Investors Need to KnowHigh Dividend Yield Stocks & See Risk Factors Before Making Any Move - earlytimes.in
Rigel Pharma: Formulating A Game Plan For 2026 - Seeking Alpha
Rigel Pharmaceuticals, Inc. $RIGL Shares Sold by Voya Investment Management LLC - MarketBeat
Pacer Advisors Inc. Buys New Position in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect - MSN
Range Financial Group LLC Makes New Investment in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals (RIGL) CFO reports multiple option exercises and share ownership - Stock Titan
Rigel Pharmaceuticals: Formulating A Game Plan For 2026 (NASDAQ:RIGL) - Seeking Alpha
Rigel enrols first subject in Phase I sickle cell disease therapy trial - MSN
With EPS Growth And More, Rigel Pharmaceuticals (NASDAQ:RIGL) Makes An Interesting Case - Yahoo Finance
Inspire Investing LLC Makes New $859,000 Investment in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Momentum Shift: Will Rigel Pharmaceuticals Inc RI2 stock beat Nasdaq index returnsInsider Selling & Free Growth Oriented Trading Recommendations - moha.gov.vn
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Could Be 23% Below Their Intrinsic Value Estimate - 富途牛牛
Assenagon Asset Management S.A. Decreases Holdings in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
(RIGL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Rigel Pharmaceuticals (NASDAQ:RIGL) Upgraded to Buy at Wall Street Zen - MarketBeat
Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats - MSN
Can Rigel Pharmaceuticals Inc. stock deliver sustainable ROEJuly 2025 Snapshot & Weekly High Return Opportunities - Улправда
Will Rigel Pharmaceuticals Inc. stock benefit from automationEarnings Growth Report & Consistent Growth Stock Picks - DonanımHaber
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
How Rigel Pharmaceuticals Inc. stock compares to market leadersJuly 2025 Breakouts & High Accuracy Trade Alerts - DonanımHaber
Rigel Pharmaceuticals announces updated data from Phase 1b study of R2891 - MSN
Rigel Pharmaceuticals Earnings Notes - Trefis
Rigel Pharmaceuticals reports promising Phase 1b study results - MSN
Behavioral Patterns of RIGL and Institutional Flows - news.stocktradersdaily.com
Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Rigel Pharma downgraded by Piper Sandler with a new price target - Quantisnow
Insiders Who Sold Rigel Pharmaceuticals Made The Right Call As Market Cap Slides By US$97m - simplywall.st
Rigel Pharmaceuticals, Inc. $RIGL Shares Bought by Globeflex Capital L P - MarketBeat
Armistice Capital LLC Acquires 84,000 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Top-Rated Stocks: Rigel Pharmaceuticals Sees Composite Rating Climb To 96 - MSN
Rigel Pharmaceuticals Reports Promising Phase 1b Study Results - TipRanks
Rigel Pharmaceuticals Inc Presents Updated Data from Phase 1b Study on R289 - TradingView — Track All Markets
Rigel Pharmaceuticals Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 13.7%Should You Sell? - MarketBeat
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛
Rigel Pharmaceuticals (RIGL) is a great momentum stock: Should you buy? - MSN
Rigel Pharmaceuticals (RIGL) Shares Promising Data from Phase 1b Study - GuruFocus
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):